Skip to main content

2 Result(s)

within David Raveh Remove this filter Pediatrics Remove this filter

and

  1. No Access

    Article

    Tumor necrosis factor-α blocking agent as a treatment for nephrotic syndrome

    We report a 13-year-old boy with refractory nephrotic syndrome (minimal change with mesangial proliferation) who failed the standard treatment protocols. There was some temporary response to large steroid dose...

    David Raveh, Ovadia Shemesh, Yaakov Jack Ashkenazi, Robert Winkler… in Pediatric Nephrology (2004)

  2. No Access

    Article

    Hyperhomocysteinemia in children on renal replacement therapy

    Hyperhomocysteinemia is an independent risk factor for the development of atherosclerosis in adult patients on dialysis or after kidney transplantation. There are few data on homocysteine (Hcy) concentrations...

    Sofia Feinstein, Ben-Ami Sela, Alfred Drukker, Rachel Becker-Cohen… in Pediatric Nephrology (2002)